Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

TRANSGENIC PLANTS WITH ENHANCED TRAITS

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

CTLA-4 aptamer conjugates

COMPOSITIONS AND METHODS FOR GENE TARGETING USING CRISPR-CAS AND TRANSPOSONS

RNA-TARGETING CAS ENZYMES

POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE

ENZYMATIC RNA SYNTHESIS

Methods and compositions for increased double stranded RNA production

Methods of synthesizing oligonucleotides using tethered nucleotides

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

A Method of Altering a Differentiation Status of a Cell

TARGETING REGULATORY B CELLS AND THEIR REGULATORS FOR CANCER IMMUNOTHERAPY

CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases

Compositions and methods for modulating Myc target protein 1

Muscle targeting complexes and uses thereof for treating dystrophinopathies

siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer

Sequence specific antimicrobials

MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY

METHODS OF TREATING BREAST CANCER

TAU ANTISENSE OLIGOMERS AND USES THEREOF

CIRCULAR POLYRIBONUCLEOTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF

A DBAIT MOLECULE IN COMBINATION WITH KINASE INHIBITOR FOR THE TREATMENT OF CANCER

METHOD FOR MULTIPLEX NUCLEIC ACID DETECTION BASED ON CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT

ONE-STEP GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY VIA GENE REPLACEMENT AND ANTI-INFLAMMATION

GENOME-EDITED BIRDS

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

Microbiome modulation of a host by delivery of DNA payloads with minimized spread

Methods for improving the health of porcine species by targeted inactivation of CD163

INHIBITION OF LET7I AS A MEANS TO ENHANCE THE PROTECTIVE EFFECT OF PROGESTERONE AGAINST STROKE

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL

Antisense antibacterial compounds and methods

OPTIMAL PS MODIFICATION PATTERN FOR HETERONUCLEIC ACIDS

CORE MASTER REGULATORS OF GLIOBLASTOMA STEM CELLS

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING USHER SYNDROME AND RETINITIS PIGMENTOSA

Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1

Compositions and methods of treating muscle atrophy and myotonic dystrophy

TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING

MODIFIED IMMUNE CELLS HAVING ENHANCED ANTI-NEOPLASIA ACTIVITY AND IMMUNOSUPPRESSION RESISTANCE

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR

METHODS FOR TREATING MACROPHAGE-MEDIATED DISEASES, AND METHODS OF IDENTIFYING AGENTS USEFUL THEREFORE

Methods for Treatment of Alport Syndrome

CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP)

TARGETING MICRORNAS TO OVERCOME DRUG TOLERANCE AND RESISTANCE

MODULATION OF CILIOGENESIS

Compositions and methods for organ specific delivery of nucleic acids

CATIONIC LIPIDS CONTAINING SILICON

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

ARTIFICIAL MICRORNA PRECURSOR AND IMPROVED MICRORNA EXPRESSION VECTOR CONTAINING THE SAME

Functionally-Modified Oligonucleotides And Subunits Thereof

METHODS AND COMPOSITIONS FOR MODULATING SPLICING AND TRANSLATION

Methods of modulating RNA translation

OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA

ANTISENSE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING

P-ethoxy nucleic acids for STAT3 inhibition

METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SITE IN EXON 5 OF THE DMD GENE

NUCLEIC ACID DELIVERY COMPLEX

NUCLEIC ACID CONJUGATE

REVERSIR TM COMPOUNDS

NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF

ANTI-ARRHYTHMICITY AGENTS

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR

MODIFIED CELLS AND METHODS OF THERAPY

Treatment methods for fibrosis targeting SMOC2

Targeting RNA viruses using inhibitors of METTL3

ANTISENSE OLIGOMERS FOR CONTROLLING CANDIDA ALBICANS INFECTIONS

Composition, kit, and method for diagnosis and treatment of taxane anticancer agent-resistant cancer

Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

Targeted control of pests and pathogens by plant delivery of 2′F-ANA-oligonucleotides

COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING

Polycomb-associated Non-Coding RNAs

Therapeutic alteration of transplantable tissues through or exposure to RNA interference molecules

EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION

MICRO RNA INTERACTIONS AS THERAPEUTIC TARGETS FOR COVID-19 AND OTHER VIRAL INFECTIONS

ALPHA-SYNUCLEIN ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

PROGRAMMABLE NUCLEASE IMPROVEMENTS AND COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION AND DETECTION

Means and Methods to Overrule Glucose-Mediated Repression of Respiration in Yeast

5'-Cyclo-Phosphonate Modified Nucleotides

Modified amine lipids

ENGINEERED TUBEROUS SCLEROSIS COMPLEX 2 POLYPEPTIDES

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Trans-splicing ribozyme targeting rhodopsin transcript and uses thereof

Long non-coding RNA gene expression signatures in disease monitoring and treatment

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

Modulation of GYS1 expression

Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products

METHODS FOR DIAGNOSING AND TREATING METASTATIC CANCER

CANCER-SPECIFIC MOLECULES AND METHODS OF USE THEREOF

Therapeutic compositions for treating pain via multiple targets

RNA-EDITING OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME

IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE siRNA

PHOSPHONOACETATE GAPMER OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES

PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS

Instruments, modules, and methods for improved detection of edited sequences in live cells

METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)

METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASES

NONCOVALENT TAGS AND RELATED METHODS FOR CYTOSOLIC DELIVERY OF MACROBIOMOLECULES

PRODUCTION OF CANNABINOIDS IN FILAMENTOUS FUNGI

CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY

HOMOLOGOUS RECOMBINATION DIRECTED GENOME EDITING IN EUKARYOTES

Methods For Preventing Titration Of Bimolecular Templated Assembly Reactions By Structurally-Determined Differential Hybridizations

A METHOD OF GENE EDITING

ANTIBACTERIAL ANTISENSE AGENTS

Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD)

Multi-targeted single entity conjugates

Methods and Compositions for the Single Tube Preparation of Sequencing Libraries Using Cas9

TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY

Micellar nanoparticles and uses thereof

GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE

Compositions of DNA molecules, methods of making therefor, and methods of use thereof

DUAL FUNCTIONAL EXPRESSION VECTORS AND METHODS OF USE THEREOF

Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD)

SPLICE MODULATING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

COMPOSITION FOR DELIVERY OF GENETIC MATERIAL

METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAIN

Methods and compositions for editing RNAs

OLIGONUCLEOTIDE

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER`S CONGENITAL AMAUROSIS

MicroRNA Compounds and Methods for Modulating MIR-21 Activity

Methods for Treatment of Alport Syndrome

Methods for Oral Delivery of Oligonucleotides

miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cells

NEOANTIGENS CREATED BY ABERRANT-INDUCED SPLICING AND USES THEREOF IN ENHANCING IMMUNOTHERAPY

CATIONIC LIPID

COMPOSITIONS FOR THE TREATMENT OF DISEASE

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES

PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION

MicroRNA Compounds and Methods for Modulating MIR-10B Activity

OLIGONUCLEOTIDES FOR SKIN CARE

Diagnosis and treatment of psoriatic arthritis

Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas

Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors

COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES

RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use

5-halouracil-modified microRNAs and their use in the treatment of cancer

Angelman syndrome antisense treatment

HNF4a saRNA compositions and methods of use

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Method of treating fatty liver disease

SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES

METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS

OLIGONUCLEOTIDES FOR HTT-1A MODULATION

Complement component C5 iRNA compositions and methods of use thereof

Products and compositions

CELL PENETRATING MOLECULE

METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING

THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

Transposon-based transfection system for primary cells

Bicyclic nucleosides and oligomers prepared therefrom

METHODS OF MAKING TARGETED VESICLES, AND COMPOSITIONS MADE THEREBY

STABILIZED THROMBIN

Compositions and methods for treating spinal muscular atrophy

COMPOSITIONS AND METHODS RELATING TO C5L2

Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence

Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS

Predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy

Method of Diagnosing Gastric Cancers Using MicroRNAs

Methods for increasing observed editing in bacteria

USE OF MIR-204 INHIBITOR TO INCREASE NURR1 PROTEIN EXPRESSION

Compounds and Methods for Use in Dystrophin Transcript

COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

RNAi agents for Hepatitis B virus infection

SERPINC1 iRNA Compositions and Methods of Use Thereof

Antisense oligonucleotides and uses thereof

Application of BAZ2B Gene as Target in Slowing Aging

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

Wheat-male sterility gene WMS and its anther-specific expression promoter and uses thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat

U1 snRNP Regulates Gene Expression and Modulates Oncogenicity

NOVEL PHOSPHORAMIDITES

ARTIFICIAL NUCLEIC ACIDS FOR RNA EDITING

COMPOUNDS AND METHODS FOR MODULATION OF SMN2

METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION

ARTIFICIAL RIBOSOMES FOR FULLY PROGRAMMABLE SYNTHESIS OF NONRIBOSOMAL PEPTIDES

Amplifiable RNAs for Therapeutic Cell Systems

Programmable nuclease compositions and methods of use thereof

Compositions and methods for promoting homology directed repair

PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING

Nucleic acid-polypeptide compositions and methods of inducing exon skipping

CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF MUSCULAR DYSTROPHY

METHODS FOR THE TREATMENT OF TRINUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

Pharmaceutical composition for preventing or treating liver cancer

TREATMENT OF SPINAL CONDITIONS WITH CHIMERA DECOY

COMPOSITIONS AND METHODS FOR INHIBITING HMGB1 EXPRESSION

INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR

Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent

Combination of antisense RNA sequences and use in the production of tilapia with degenerated sexual organs

CELL ENGINEERING USING RNAs

Pharmaceutical compositions comprising gene-corrected primary cells

COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Double-stranded RNA molecule targeting CKIP-1 and use thereof

METHODS FOR IDENTIFICATION OF GENETIC MODIFIERS AND FOR TREATING NUCLEOTIDE REPEAT DISORDER

Methods for preventing and treating or diagnosing coronavirus infection

OLIGOMERIC NUCLEIC ACID MOLECULE AND APPLICATION THEREOF

RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN

DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES CONTAINING A TRILOOP

Compounds and methods for reducing ATXN2 expression

COMPOUNDS AND METHODS FOR MODULATING SMN2

Compounds and methods for reducing ATXN3 expression

T cells with improved functionality

Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier

Cleaving pre-fusion state SARS-CoV-2 spike protein

Compositions and methods of treating muscle atrophy and myotonic dystrophy

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

USE OF miRNA IN PREPARATION OF A DRUG FOR PREVENTING AND TREATING OSTEOARTHRITIS, AN EXOSOME HIGHLY EXPRESSING miRNA AND USE THEREOF

CELL MEMBRANE PENETRATING CONJUGATES FOR GENE EDITING

Compositions and methods to treating hemoglobinopathies

Treatment of tumors with miRNA targeting CDK4/CDK6

Modified double-stranded RNA agents

REGULATION OF NUCLEOTIDE EXCISION REPAIR (NER) BY MICRORNA FOR TREATMENT OF CANCER

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Compounds and methods for modulating PLP1

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

METABOLIC BENEFITS OF SHORT MIR-22 MIRNA ANTAGOMIR THERAPIES

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)

Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)

Modified Rhodamine Dye and use Thereof in Biological Assays

Gene therapy for retinitis pigmentosa

Targeted Delivery of Therapeutic Molecules

NEW CONJUGATED NUCLEIC ACID MOLECULES AND THEIR USES

Drug delivery systems containing oxidized cholesterols

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Antisense nucleic acids

CONTROL OF PLANT PESTS USING RNA MOLECULES

Modulating the cellular stress response

KLF11 siRNA for treatment of diabetes and obesity

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES

CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF

dsRNA Directed to Coronavirus Proteins

Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4

Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof

NOVEL MAD NUCLEASES

Methods for Promoting Reinnervation of Auditory Hair Cells

Treatment of staphylococcal disorders

RNA nanoparticles and method of use thereof

RNAi CONSTRUCTS AND METHODS FOR INHIBITING MARC1 EXPRESSION

Drug Delivery Particle and Method for Producing the Same

Detection of analytes by enzyme-mediated strand displacement reactions

COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163

Identification of a JAK2 Mutation in Polycythemia Vera

CONJUGATED OLIGONUCLEOTIDES FOR TISSUE SPECIFIC DELIVERY

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and their uses directed to huntingtin

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ANTISENSE OLIGONUCLEOTIDES TARGETING CARD9

Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Compositions and methods of treating muscle atrophy and myotonic dystrophy

LIPID COMPOSITIONS

Compositions and methods for delivery of biomacromolecule agents

APP MODIFICATION VIA BASE EDITING USING THE CRISPR/CAS9 SYSTEM

Expression of miRNAs in Placental Tissue

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Compositions and methods for treatment of cardiac diseases

Oligonucleotides targeting RNA binding protein sites

Targeting Ligands

USE OF miRNA 148 CLUSTER AS MARKER FOR DIAGNOSING AND/OR TREATING COGNITIVE IMPAIRMENT-ASSOCIATED DISEASES

SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES

METHODS FOR THE TREATMENT OF TRINUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MLH1 ACTIVITY

L-OLIGONUCLEOTIDE INHIBITORS OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2)

COMPOSITIONS AND METHODS FOR NON-ANTIBIOTIC TREATING OF BACTERIAL INFECTIONS BY BLOCKING OR DISRUPTING BACTERIAL GENES INVOLVED IN VIRULENCE OR VIABILITY

Enzymes with RuvC domains

METHODS AND COMPOSITIONS FOR TREATING ASTHMA

COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY

In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use

METHODS OF PRODUCING T REGULATORY CELLS, METHODS OF TRANSDUCING T CELLS, AND USES OF THE SAME

MULTIPLEX GENOME EDITING OF IMMUNE CELLS TO ENHANCE FUNCTIONALITY AND RESISTANCE TO SUPPRESSIVE ENVIRONMENT

COMPOSITIONS AND METHODS FOR MODULATION OF LMNA EXPRESSION

ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION

Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease

Methods and compositions for preparing tagatose from fructose

Nuclease-mediated genome editing of primary cells

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription